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1.1 INTRODUCTION
In August 2019, S3 Solutions and Elemental were commissioned by Health and Wellbeing, Health 
Service Executive,	 the	 National	 Office	 of	 Suicide Prevention and	 the	 Department	 of	 Health	 to	
conduct	 an	 evaluability	assessment of Social Prescribing in Ireland. This assessment is a key input 
to the development of a monitoring and evaluation framework for Social Prescribing in Ireland.
The evaluability assessment within this report is limited to twelve Social Prescribing projects in operation in 
Ireland	identified	by	the	HSE	at	the	project	commencement	stage.
1.2 OBJECTIVES
The objectives of this project were, to undertake an evaluability assessment of Social Prescribing 
projects in Ireland by:
1. Providing an overview and synthesis of current Social Prescribing services and programmes
in Ireland in terms of the underlying theory of change and programme logic models
2. Assessing the capacity of the current Social Prescribing system in Ireland to collect process, 
output and outcome data to support impact evaluation.
3. Developing a Minimum Data Outcomes Framework for Social Prescribing services in Ireland, using 
a consensus-based methodology, and providing recommendations on how to establish a system 
to collate and report on outcomes nationally.
1.3 REPORT STRUCTURE
This report is framed around the three dimensions of Evaluability Assessment (Davies, 2013)1, including:
a. Evaluability in principle (i.e. clarity of the intervention and its theory of change)
b. Evaluability in practice (i.e. what data are available and what systems are in place to provide it)
c. Evaluability	usefulness	(i.e.	what	interest	do	stakeholders	have	in	using	evaluation	findings	for	
example, to enable strategic decision making).
Applying this structure, the report also includes: 
• An examination of the Social Prescribing landscape in Ireland
• An Evaluation Index, developed by S3 Solutions and Elemental, to show the current range of
evaluation practice in Ireland
• Knowledge and learning from other systems, models, policy and practice around Social Prescribing
• The Primary Care landscape and strategic context within which Social Prescribing operates in
Ireland
• The consensus based feedback on a Minimum Data Outcomes Framework for Social Prescribing in
Ireland.
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1.4 WHAT IS SOCIAL PRESCRIBING?
There	are	many	definitions	and	descriptions	of	Social	Prescribing.	For	 the	purposes	of	 this	 report,	 the	
definition	employed	by	 the	All	 Island	Social	Prescribing	Network	was	considered	the	most	useful.	This	
Network is a body established to share knowledge and best practice, to support Social Prescribing at local 
and national levels and inform good quality research and evaluation.
Social Prescribing is a means of enabling GPs and other frontline healthcare professionals to refer patients 
to a Link Worker - to provide them with a face to face conversation during which they can learn about the 
possibilities and design their own personalised solutions, i.e. ‘co-produce’ their ‘social prescription’- so 
that	people	with	social,	emotional	or	practical	needs	are	empowered	to	find	solutions	which	will	improve	
their health and wellbeing, often using services provided by the voluntary and community sector. It is 
an	innovative	and	growing	movement,	with	the	potential	to	reduce	the	financial	burden	on	the	NHS	and	
particularly on Primary Care2.
In most cases, Social Prescribing focuses on:
• addressing the social determinants of health
• a referral to a Link Worker ‘The essential item in Social Prescribing is the Social Prescribing Link 
Worker, who has the time and the personality to see the patient and refer to a menu of possible 
options’3
• the resources of the health, local government and community & voluntary sectors working 
together to provide a sustainable solution
• the presence of a high-quality range of local community assets to facilitate a referral to non-
medical support for issues that underpin or exacerbate medical issues, and
• evaluation – measuring the impact of the Social Prescribing process in providing a suitable 
outcome and proving the case for funding.
1.5. WHAT IS AN EVALUABILITY ASSESSMENT?
Evaluability assessment (EA) is a systematic approach to planning an evaluation of projects. It seeks to 
assess:
“the extent to which an activity or project can be evaluated in a reliable or credible fashion”4
An evaluability assessment is designed to enable informed and strategic decisions to be made about 
whether and how to evaluate a programme or policy in a reliable and credible way (Wholey 1979)5. An 
evaluability assessment is not an evaluation, however, it is likely to have consequences for how an evaluation 
is designed, the framework against which monitoring and evaluation is carried out and sometimes on the 
design of a project or intervention itself.
2 https://www.socialprescribingnetwork.com/
3 GLA, Better Health For All Londoners: Consultation on the London Health Inequalities Strategy (August 2017) https://www.london.gov.uk/sites/ default/files/draft_health_
inequalities_ strategy_2017.pdf
4 OECD-DAC (2010) Glossary of key terms in evaluation and results-based management. Paris: OECD-DAC.
5 Wholey, J. S. (1979). Evaluation: Promise and performance. Washington, DC: The Urban Institute
1.6 METHODOLOGY
This evaluability assessment is informed by the following activity, carried out between August 2019 and 
March 2020.
1.6.1. Data Collection
A mixed method approach was used comprising semi-structured interview, small group discussion and 
online survey. A consultation framework was developed following an initial meeting with members of 
the project steering group (see 9.5).
An	initial	sample	of	twelve	Social	Prescribing	projects	were	identified	by	the	HSE,	all	of	which	are	currently	
funded by the HSE, Department of Health and/or Healthy Ireland, to deliver Social Prescribing services 
in	Ireland.	One	of	the	twelve	projects	includes	six	unique	Social	Prescribing	services	–	each	with	different	
experiences and contributions. The following summarises the key data collection activity:
• The research team travelled to the project locations across Ireland to carry out interviews. Twelve 
semi-structured interviews and/or group discussions were facilitated, and 29 individuals 




(n = 4). 
• Four members of the research team attended (as both speakers and participants) the All-Ireland 
Social Prescribing Conference in December 2019. The researchers participated in small group 
discussions with other attendees (organised by the conference). In addition, the conference was 
used to distribute an online survey to delegates (10 responses were received).
• One member of the research team attended and participated in a small group discussion at a 
regional Social Prescribing event in October 2019. Participants included stakeholders involved in 
Social Prescribing and/or community health projects. The event was hosted by HSE 
representatives and community  and voluntary sector organisations in CHO1 (Community 
Healthcare Organisation Area 1).
• A structured review of qualitative research studies and policy documentation in relation to Social 
Prescribing and wider health agenda in Ireland and in the UK was completed. An initial list of 
relevant research reports and policy documents were provided by members of the steering 
group. The following resources were used to search for relevant research, papers or reviews on 
the evaluability of Social Prescribing, evaluation of Social Prescribing and theory of change/
outcomes/measuring impact within Social Prescribing:
Building the Capacity for the Evaluation of Social Prescribing: An Evaluability Assessment
8 9
o National Institute for Health and Care Excellence (NICE)6
o NHS Evidence7
o Social Care Institute for Excellence8
o The National Lottery Community Fund9
o The Kings Fund10
o  NESTA11
The researchers also searched Google to identify any relevant grey literature whilst the reference 
lists of relevant research reports were used to identify any additional studies or research of interest. 
The review of literature was used to identify current practice and how it may relate to Social 
Prescribing in Ireland and lessons to be learned from elsewhere.
• A further eight semi-structured interviews and/or small group discussions were carried out with 
individuals that have been involved in developing, delivering, funding or researching Social 
Prescribing projects. Individuals	were	identified	by	members	of	the	steering	group	and	through	
researchers	existing	network of contacts. See appendix 2 for a list of organisations/individuals 
that contributed to the research.
• Facilitation of a co-production event focused on the development of a Minimum Data Outcomes 
Framework, attended by 24 stakeholders including Social Prescribing Link Workers, statutory 
agencies and community and voluntary sector representatives.
1.6.2. Data Analysis
Qualitative data analysis was conducted using both thematic and narrative approaches12. Categories were 
developed, coded and reduced. Survey data, researchers’ observations and thematic data from interviews 
was cross referenced in order to identify emergent themes and issues and to explore the relationships 
between issues13. Participant sampling and data collection continued until no new conceptual insights 
were generated and the research team felt they had gathered repeated evidence for the thematic analysis.
1.6.3. Consensus Based Methodology
The principles of co-production and consensus based methodology were applied in the following ways:
• Co-design of consultation framework with project steering group
• Presentation	of	early	thematic	findings	to	relevant	audience	(at	All	Ireland	Conference)	










12 Lewis-Beck, M. S., Bryman, A. & Liao, T. F. (Eds.) (2004). The SAGE encyclopaedia of social science research methods (Vols. 1-3). Thousand Oaks, CA: SAGE Publications 
13 Morgan, D. L. (1997). Focus groups as qualitative research (2nd ed.). Thousand Oaks, CA: Sage.
• Three	meetings	of	the	project	steering	group	to	reflect	on	findings	and	shape	the	direction	of	the	
research
• Facilitation of a co-design workshop involving 24 stakeholders to agree ‘minimum outcomes’.
Over 280 stakeholders were engaged in the surveys, focus groups, conference sessions, workshops 
and meetings undertaken as part of this commission. A list of organisations represented in this 
consultation is included in Appendix 2. 
1.7. LIMITATIONS 
Efforts	 have	 been	 made	 to	 ensure	 the	 validity	 and	 reliability	 of	 findings	 through	 multiple	 method	
consultation.	 One area of limitation is in the extent of engagement from GPs and Primary Care 
professionals. Input from these sectors was primarily by those already involved in the Social 
Prescribing Network and therefore already advocates of Social Prescribing. Attempts were made 
to engage a network of GPs through the Department	of	Health,	 however	 the	 planned	 engagements	
to	 test	 findings	 and	 scrutinize	 the	 Minimum	 Data Outcomes Framework coincided with the 
outbreak of COVID-19 and understandably reduced the potential for Primary Care professionals 
to input. This is now proposed as a recommendation. 
The semi-structured interviews and focus groups during site visits focused primarily on Social 
Prescribing Link Workers and managers of community & voluntary organisations. The process 
included minimal amount	of	service	user	involvement,	offering	a	potential	limitation	regarding	the	effect	
of	adding	new	data	collection processes to a Social Prescribing service. 
1.8. SUMMARY 
The objective of this project is not to evaluate Social Prescribing in Ireland, nor is it intended to be 
a guidance document on how to carry out evaluation of Social Prescribing. Moreover, the report 
documents an assessment of the evaluability of Social Prescribing, and the current capacities of 
the Social Prescribing system	 &	 stakeholders	 to	 collect	 data	 that	 would	 enable	 effective	
evaluation.	Some of	 the	 emerging	 concepts, such as the Evaluation Index and the Minimum Data 
Outcomes Framework may well assist new and existing projects with evaluation design. 
1.9. COVID-19 
Data collection for this report was completed before COVID-19 restrictions were 
introduced. We understand that the requirement to move services online and operate digitally may 
have implications for evaluation. We are  aware that	 in	 some	 cases,	 referrals	 to	 Social	 Prescribing	
projects	 have	 increased	significantly. GP	practices	and Primary Care Networks in England have used 
text messages to contact their patients with a link to a self-referral form that enabled patients to 
self-refer directly to Link Workers rather than having to visit GPs for support. We are unclear how 
Social Prescribing projects are adapting evaluation practice in response to COVID but	it	may	have	
implications	for	how	the	findings	of	this	report	are	implemented	in	the	coming	months.
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2.1. OVERVIEW OF SOCIAL PRESCRIBING IN IRELAND
At the time of commission (August 2019), this Evaluability Assessment focused on twelve Social Prescribing 
projects	funded	by	the	HSE	(Health	and	Wellbeing	and	National	Office	for	Suicide	Prevention	and	Healthy	
Ireland, DoH). These projects were targeted for site visits by the research team. Two of the projects are 
located in Primary Care settings, and ten in community and voluntary sector settings. See Appendix 1 for 
detail on the twelve projects.
During the course of this evaluability assessment, the number of Social Prescribing projects in Ireland 
increased. A €20m ‘Sláintecare’ Integration fund was launched by the Department of Health in March 201914
and in September 2019, 122 successful projects were announced, including the expansion of three existing 
Social	Prescribing	projects	and	the	introduction	of	six	new	projects	that	either	explicitly	define	themselves	
as Social Prescribing or involve community referral process through a designated worker and thus align to 
the principles of Social Prescribing15.
14 https://www.gov.ie/en/press-release/a98320-minister-for-health-announces-20-million-funding-for-122-slaintecare/
15 https://www.gov.ie/en/press-release/a98320-minister-for-health-announces-20-million-funding-for-122-slaintecare/
Image - location of 12 Social Prescribing projects 
provided to research team in August 2019.
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Evaluability in principle relates to the nature of an intervention design16, and the extent to which it has a 
plausible, theoretically sound, theory of change. It questions if there a clear understanding of how and why 
the intervention’s desired changes are expected to happen in a particular context. In this case, is the theory 
of change for Social Prescribing in Ireland plausible?
Evaluability in principle focuses on whether it is possible to evaluate the intervention as has been described 
or is being implemented.
3.2. SOCIAL PRESCRIBING IN IRELAND: EVALUABILITY IN PRINCIPLE
A key purpose of the consultations with projects was to articulate the underlying theory of change for 
Social Prescribing in Ireland. The logic model framework was used to guide these conversations. The 
following key points were taken from the thematic analysis of interviews carried out during site visits to 
the Social Prescribing projects.
The main participant groups accessing the projects in this assessment are those with mild or 
long term mental health problems, depression, anxiety, vulnerable groups (e.g. single parents), 
people who are socially isolated, and those who frequently attend either primary or secondary 
health services.
2. Those interviewed asserted the view that an individual’s health is determined primarily by a range 
of social, economic, and environmental factors. Thus, Social Prescribing interventions aim to help	
participants	to	take	control	of	their	own	health	and	address	their	specific	or	person	centred	needs 
in a holistic way.
3. The role of the Link Worker and particularly the initial assessment and follow up meetings were 
cited consistently as having psychosocial or therapeutic attributes in themselves. The in-depth 
initial assessments involve an exploration of ‘root causes’ of an issue, motivational interviewing 
and goal setting. Some Link Workers make appointments on behalf of participants and 
accompany them to appointments or activities, and some continue to meet participants over an 
extended period	of	time	depending	on	need.	Kimberlee	(2015)17	classified	Social	Prescribing	
models	into	signposting, light, medium and holistic, according to a range of aspects and the level 
of support provided by Link Workers to patients. The projects analysed in Ireland primarily align 
with the ‘holistic’ model which includes a clear referral pathway, a holistic view of a person’s needs 
and aspirations, and an intense level of support provided by the Link Worker.
4. All stakeholders interviewed referred to improvements in emotional health, wellbeing, and social 
connectedness as being the primary outcomes for individuals. These outcomes were referred to 
as observable (and therefore measurable) changes in behaviours, experiences and circumstances. 
These improvements are, it is hypothesised, the result of the interaction between the Link Worker 
and person as well as the community or health based service and the person.
16 Davies, R. (2013). Planning evaluability assessments. a synthesis of the literature with recommendations. DFID Working paper 40. Cambridge, UK: Department for International 
Development
17 Kimberlee R. 2015: What is social prescribing? Advances in Social Sciences Research Journal 2, 1
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5. Participants also referenced other (often unintended) outcomes including improved employment 
status of individuals, skills acquisition, improved income through accessing appropriate welfare 
entitlement, improved housing/accommodation and improved family and other relationships.
6. The projects consistently referred to a belief that the improvements arising from a Social 
Prescribing project (such as reduced anxiety, reduced isolation and improvements in connections) 
results	in	a	reduction	in	demand	for	primary	and	community	care	and	thus	offers	resource	savings	
and a contribution to the long-term sustainability of ‘the system’ (i.e. the healthcare system). But, 
given that funders are not directly involved in the interaction within the Social Prescribing process, 
they require data to evidence the anticipated/expected outcomes and to demonstrate a more 
nuanced understanding of the intervention i.e. what works for whom in what context. There was 
only one project that could provide evidence of outcomes at a systems level during the 
consultation. This evidence relates to a reduction in a mental health waiting list from 40 to 6 over 
an 18 month period of time. This was reported directly by a mental health liaison nurse who 
attributed much of this reduction to the availability of the Social Prescribing Link Worker: “I have 
been able to refer people on the waiting list to [SP Link Worker} and those people have not come 
back onto my waiting list”. This evidence was collated directly by the mental health liaison nurse 
and shared with the researchers because of a personal belief in the potential of Social Prescribing.
7. Those interviewed expressed the opinion that the exchange between the Link Worker and the 
participant is the key mechanism for change in the Social Prescribing process. The premise is that 
this interaction produces the impetus and, in some cases, the desired change itself (i.e. an 
improvement in the person’s wellbeing, situation or circumstances).
8. The level or intensity of the Link Workers intervention varies from project to project, it may 
therefore be challenging to measure attribution. A consistent approach to evaluation could enable 
an analysis or	comparison	of	the	effectiveness	of	varying	approaches.
a. Interviews	identified	variance	in	the	role	of	the	Link	Worker.	In	addition	to	the	initial	
assessment meeting (as per point 3 above), there were examples (n = 5) where the Link 
Worker directly establishes and facilitates interventions. Examples of interventions 
include: 8 week therapy based workshops delivered by the Link Worker, weekly walking 
groups or exercise classes, arts and crafts workshops facilitated by the Link Worker. Where 
there is evidence of direct intervention beyond the initial therapeutic assessment, there 
may be a stronger association between the role of the Link Worker, and a positive outcome 
or otherwise. Conversely, in some cases the Link Worker role is more of a signposting 
function, this tended to be the case for projects that are located in Primary Care rather 
than communit sety tings.
b. The vast majority of participants are referred to one or multiple community based services. 
The	onward	referrals	are	usually	nonclinical	interventions,	offering	activities	or	programmes	
seeking	to	benefit	the	health	and	wellbeing	of	participants	with	social,	emotional	or	practical	
needs. The implication for evaluation is in the attribution or contribution to an outcome or 
change (if applicable). Where a positive outcome is achieved and can be evidenced, it will 
raise the questions: ‘to what extent was the change caused by the intervention of the Link 
Worker, or by the community based service’? and does it actually matter? This is likely to be 
a challenge for any evaluation of Social Prescribing projects but could potentially be captured
through qualitative evaluation methods. 
9. The inclusion of self-referrals (i.e. where a participant makes direct contact with the Social 
Prescribing project and does not come through Primary Care or community services) within 
evaluation was raised by four stakeholders as having the potential to create bias and ‘distort results
because of a perceived pre-existing motivation for change’. The majority of the projects (n=8) 
accept self-referrals. For most of these (n = 6), this was primarily due to the limited participation of 
GPs and Primary Care Teams within the Social Prescribing projects and therefore minimal referrals 
received from these sources. Alternatively self-referrals could be a very interesting comparison 
group.
Each of the points above has been coalesced into a summary theory of change for Social Prescribing in 
Ireland (based on the projects). This theory of change is presented using the Logic Model overleaf.
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4.1. INTRODUCTION
Evaluability in practice considers the availability of relevant data and the systems needed to make that 
data available. Evaluability depends on access to data and the practicality and cost of collecting it. The 
consultation, conducted as part of this project, explored existing approaches to evaluation across the 
twelve projects as well as other evaluation activity in relation to Social Prescribing in Ireland. Across the 
projects,	there	is	significantly	more	evidence	of	data	collection	at	the	individual	level	than	at	a	system	level	
(i.e. healthcare system or community and voluntary sector). However, such evidence is mostly focused 
on anecdotal and qualitative information and is likely to include bias and unlikely to be acceptable 
to commissioners in terms of future funding in a more sustainable way. The following summary 
points are noted:
1. All	projects	are	gathering	quantitative	data	relating	to	number	and	profile	of	participants,	number	
of engagements, referral sources and destinations, uptake of referrals etc. These are in the main 
gathered by Link Workers and stored on secure spreadsheets within a host organisations 
operating system – usually a community and voluntary organisation. Three of the twelve projects 
are using a purpose built digital tool to collate and store data.
2. Six projects are using qualitative and anecdotal participant feedback as their main source of 
evidence.  All projects can draw on powerful and impactful participant case studies that highlight 
changes in for example, mental and emotional wellbeing, social connectedness, volunteering, 
employment etc. Projects are typically using self-developed case study templates and 
information is usually gathered directly by Link Workers. In the main, case studies are used to 
promote the service or develop connections and links to potential inward and outward referral 
agents.
3. Six projects are using validated tools to gather pre and post data on participant wellbeing 
outcomes. This data is typically gathered by Link Workers at initial assessment and follow ups 
occur either face to face or via telephone, usually at 6 week, 12 week or 6 month intervals. The 
range of tools currently being used by projects include:
a. The World Health Organisation- Five Wellbeing Index (WHO-5)18
b. Shortened Warwick Edinburgh Mental Wellbeing Scale19
c. Wheel of Life Coaching Tool or Wellbeing Star20
d. Measure Yourself Concerns and Wellbeing (MYCAW)21






4. Three projects had external and independent evaluations conducted on their work. Two of 
the evaluations were still ongoing at the time of this report, one was completed in 2015. In the 
2015	evaluation,	findings	highlight	statistically	significant	positive	changes	in	the	scores	for	
wellbeing, anxiety depression and community involvement. GP visits also reduced for 
participants. Qualitative	data	backed	up	quantitative	findings	enabling	the	evaluation	to	conclude	
that	“Social	Prescribing……. has shown very positive results for participants and other 
stakeholders”. This work has provided the impetus for the development and funding of several of 
the other Social Prescribing projects23.
5. Three projects reported that they are storing pre and post data, from both validated tools or from 
their own developed surveys, on excel spreadsheets, but are not using or analysing the data. The 
three projects using a digital system to manage data, are also using validated tools.
6. Despite the majority of projects reporting a belief that their Social Prescribing projects are 
achieving outcomes at the ‘system level’ (i.e. GP attendance, Waiting Lists, ED attendance), only 
two projects located in non-Primary Care settings had data to support this. These data sources 
included mental health assessment waiting lists and GP attendances. This was perceived as a 
major barrier for most projects.
7. A randomised control trial (RCT) is currently ongoing in Ireland. RCSI (Dept. of General Practice, 
Royal	College	of	Surgeons)	is	examining	the	effectiveness	of	Link	Workers	on	improving	the	
health and wellbeing of individuals with multi-morbidity. It is also examining the impact of Link 
Workers on healthcare utilisation of individuals with multimorbidity. This is a multi-site study with 
Link Workers based in GP practices in Dublin, Cork, Waterford and Limerick.
4.2. EVALUATION INDEX
To capture the breadth of current evaluation approaches in Ireland, S3 Solutions and Elemental devised 
an ‘Evaluation	Index’	(EI),	presented	overleaf.	This	is	similar	to	the	recognised	levels	of	scientific	
evidence24. The EI was designed to help frame the summary of the conversations on how projects are 
currently measuring the outcomes and impacts of Social Prescribing. It is not intended as a method for 
completing evaluations nor is it a hierarchical progression pathway of evaluation. All approaches to 
evaluation can be considered valid depending on the purpose and objective of that evaluation. By 
framing ‘where we are now’ in relation to	evaluation	practice,	the	EI	assists	in	the	identification	of	areas	
for	development.
The	EI	shows	five	approaches	to	evaluation	currently	used	by	Social	Prescribing	projects.	These	range	
from	 gathering standard quantitative data combined with anecdotal participant case studies at 
‘Approach one’ through	 to	 Randomised	 Control	 Trials	 at	 ‘Approach	 five’.	 Currently,	 three	 projects	
are	 identified	 as	 adopting	 ‘Approach four’ (only one of these is a community based setting), three 
projects at ‘Approach three’ and the remainder (six projects) between ‘Approaches one and two’. Thus, 
evaluation in Ireland largely aligns with Bickerdike et al (2017)25 who concluded there was	
insufficient	methodologically	robust	evidence	to	assess success or value for money in Social Prescribing.
23 Donegal: Social Prescribing for Health and Wellbeing Evaluation Report (2015) Evaluation of six social prescribing demonstration sites across County Donegal, involving 
24 https://libguides.winona.edu/c.php?g=11614&p=61584
25 Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7(4)
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Evaluation Features Approach 1 Approach 2 Approach 3 Approach 4 Approach 5
Collects quantitative 




Gathers qualitative data 
anecdotally, usually 
as case studies to be 
included in internal report 
documents
Gathers data on medical 
conditions of referrals
Uses internally developed 
surveys to  gather 
perceived wellbeing data
Uses validated tools to 
gather pre and post data 
on participant wellbeing 
outcomes
Data and outcomes 
evaluated independently 
and externally
Collects and shares 
clinical data with PCTs on 
waiting lists, clinical 
outcomes, attendances 
Compares data with 
national data sets or 




It is fair to say that no single Social Prescribing model exists in Ireland. The EI was shared with Social 
Prescribing stakeholders via survey and telephone interviews to identify the preferred approach to 
evaluation.
Stakeholders indicated that ‘Approach 3’ should represent a preferred approach (including 
independent evaluation) with Approach 4’ representing the ideal or aspirational approach to 
evaluation.
The main barriers preventing projects operating at Approaches 3 and 4 include: lack of capacity to 
carry out analysis of data, and/or lack of relationship/engagement with Primary Care Teams to access 
‘system’ data. This is explored further.
4.3. PRACTICAL IMPLICATIONS FOR EI APPROACHES 
There are variances in the twelve Social Prescribing projects consulted in this assessment, each of which 
has potential implications for the development and implementation of an ‘Approach three and four’ 
evaluation. These include:
4.3.1. Relationship with GPs and Primary Care professionals
Whilst most projects have received some level of referral from Primary Care settings, four projects 
reported positive working relationships between Primary Care Teams and their Social Prescribing project 
in relation to evaluation. This includes sharing waiting list data and providing referrals to Link Workers 




further evidence is required by Primary Care Teams of the merits and outcomes of Social Prescribing before 
fully ‘buying in’, but in the absence of referrals and ‘system data’, how can that evidence be gathered?. It is 
noteworthy that those with fewer levels of referrals from Primary Care Teams are more reliant on anecdotal 
evaluation evidence.
The	location	of	a	Link	Worker	(i.e.	who	employs	the	Link	Worker)	may	influence	the	relationship	with	Primary	
Care Teams and therefore the extent to which a project can access data on waiting lists, GP attendances or 
other	clinical	data	that	might	speak	to	the	cost	benefit	of	the	intervention.	The	majority	of	projects	(10)	who	
engaged in this process were located in a community setting, frequently within a Family Resource Centre 
or a local community development organisation. Four projects reported a positive working relationship 
with Primary Care Teams compared to eight projects reporting negative or no relationship. The reliance on 
personal relationships to access ‘system’ data is not a long term sustainable solution. The lack of access to 
system	data	may	impede	future	‘Approach	4’	evaluation	efforts.
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4.3.2. Project Resources
Eleven	of	the	twelve projects reported employing	part	time	LinkWorkers at	the	time	of	site visits, with five	
of those projects now employing full time Link Workers (result of funding from Sláintecare). Part time hours 
vary from 12 to 24 hours per week. The average case load for Link Workers was estimated to be in the range of 
60 – 90 per annum, depending on the extent of the Link Worker role (i.e. delivery and/or signposting) and the 
number of hours worked.
There	was	significant	variation	in	the	duration	of	the	Social	Prescribing	intervention	with	reports	varying	from	
1-2 weeks to as long as 6-9 months of engagement. The approach across all projects is very much person 
centred with a consistent underlying principle of ‘moving people on’ at the earliest appropriate moment. The 
focus across projects is in empowering participants rather than creating a reliance. All Link Workers reported 
that the priority focus within their limited hours was on engaging participants and that an extremely limited
amount of time was attributed to administration and subsequently to evaluation. Most Link Workers reported 
doing more than their allocated paid hours in order to manage and administer workloads. This creates a 
potential challenge for any enhanced data collection responsibilities.
4.3.3.Capacity for Evaluation and Data Collection
Eight projects referenced the need for training, capacity building and/or support in terms of implementing 
evaluation practice. Understanding outcomes and how to use validated tools were cited as key challenges.
Furthermore,	Link	Workers	are	employed	by	a	variety	of	host	organisations,	some	 carry out another	
role	on 2 or 3 days per week. Each organisation has its own existing monitoring and reporting responsibilities, 
often determined by funders, and therefore an integrated or complementary data collection system is an 
important consideration	 in	 any	 future	 framework. The	 majority	 of	 projects	 (n	 =	 8)	 identified	 that	 they	
operate	 the	 Social	 Prescribing project ‘at a loss’ with no management fee or contribution to core 
overhead costs, therefore investing in evaluation based resources or support is down the list of priorities.
Many Link Workers also expressed concern than ‘evaluation could subsume the intervention’ which ‘appears 
counter intuitive given the principles of how Social Prescribing should work’. Training on the appropriate and 
subtle use of validated tools for data collection will be an important consideration for future evaluation. 
4.3.4. Funding Environment
The projects engaged were funded from several sources including HSE Health & Wellbeing, HSE National 
Office	of	Suicide	Prevention,	Healthy	Ireland,	SICAP	(Social	Inclusion	and	Community	Activation	Projects)	and	
some received ‘top up’ funds from Sláintecare. All projects at the time of visit were funded on an annual basis 
meaning that Link Workers are placed on statutory notice in February/March each year, increasing the risk 
that they may move on. This is important in a highly person centred and relationship based intervention. 
This	 report	 acknowledges	 that	 different	 approaches	 to evaluation have	 different	 uses	 for different	
stakeholders. For projects, participant outcomes, service improvement outcomes and funding security are of 
primary	concern,	therefore	EI	Approaches	2-3	may	be	sufficient.	For	funders	and	Primary	Care	Team’s,	
value for money and resource savings may be a priority and therefore Approaches 3-4 may be 
essential. Clarity in terms of what is expected from evaluation by funders will assist projects with evaluation 
design and implementation. 
4.3.5.Systems for Data Collection
The experience of the existing network of projects is a variety of data management systems and processes. 
Most are using basic technical systems including Microsoft Excel to store and manage project data 
whilst three are using a purpose built digital system to manage projects in their entirety. Some 
sectors are already more advanced than others. It is important to note that whilst an area may be 
advanced in its Social Prescribing ecosystem	and	delivery	model,	 it	may be	primitive	 in	terms	of	having	fit	
for	purpose	systems.	It	 is	evident	that the projects involved in this study in the main, do not have budgets 
to invest in IT to make themselves “digitally	enabled”,	to	spend	on	staff	or	volunteer	training,	nor	are	they	
sufficiently	resourced	to	commission	independent support with evaluation. The implication for 
evaluation currently is that data is likely to be provided	in	a	wide	variety	of	formats	making	it	difficult	to	
compare	and	analyse.
4.4. SUMMARY OF KEY FINDINGS: EVALUABILITY IN PRACTICE
• Everyone involved in the process associated with this project is supportive of the need for a 
Minimum Data Outcomes Framework and is committed to building more evidence for Social 
Prescribing. To this end it is essential to work towards embedding (outcome) data collection into 
service delivery.
• There appears to be ‘buy in’ from both commissioners and practitioners for guidance around the 
evaluation of Social Prescribing in a more accessible, clear and structured way.
• Uncertainty remains around what to measure, how to measure it and which tools should be used.
• There are challenges around the capacity and resources of organisations to measure outcomes 
and impacts.
• The importance of shared resources and shared learning for	evaluation	was	identified	as	crucial.
• There are many different Social Prescribing delivery models and projects are at different stages/
levels of operating.
• The level of buy-in from Primary Care Teams differs from project to project and is largely 
determined by personal relationships. This has an impact on access to ‘system level’ data.
• The use of other external data (i.e. national datasets and RCTs) to build the case would be useful, 
but projects need support to do this.
• There are issues relating to multi annual funding cycles and under resourced projects. In addition, 
there appears to be limited onus on projects to provide impact data currently to funders.
• Projects need clear direction from commissioners and Primary Care Teams on what is useful for 
them and what helps them to recommission & fund.
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The third aspect of evaluability is the potential usefulness of evaluation26 of Social Prescribing in Ireland; this is 
explored from a number of contexts, set out below:
5.2. FUNDERS AND COMMISSIONERS
The	consultation	process	for	this	assessment	identified	that	the	evaluation	requirements	placed	on	projects	
by funders is reasonably limited.
As funders come under increasing pressure from the Social Prescribing ‘movement’, the onus will be on 
providing	sufficient	evidence	to	justify	investing	in	Social	Prescribing	in	a	more	sustainable,	long	term	and	
systematic way. The ‘onus’ relates to a combination of all stakeholders involved in the Social Prescribing 
process. This evaluability assessment, and the accompanying Minimum Data Outcomes Framework, may 
influence	how	Social	Prescribing	projects	are	planned,	implemented	and	evaluated	in	the	future.	A	common	
outcomes framework and enhanced data collection will provide funders with evidence of impact of their 
investment	and	facilitate	the	exploration	of	cross	departmental	benefits	and	funding	as	well	as	assess	the	
value of Social Prescribing against other services / areas of investment.
The consultations with projects consistently referenced perceived outcomes that go beyond health. Multiple 
projects reported enhancements to employment status of participants, improved tenancies, and increased 
likelihood	of	sustaining	tenancies,	of	 increased	access	to	appropriate	benefits	and	welfare	and	 increased	
levels	of volunteering. The challenge for projects, funders and evaluators is in how this data can be captured 
and how it can be linked to and attributed to the intervention.
It is likely that the growth of Social Prescribing as a process, will move beyond traditional ‘health focused funds’ 
and therefore the framework will be of interest to a wider body of funders and government departments.
5.3. PRIMARY HEALTH CARE NETWORKS (INCLUDING GPS)
The individuals interviewed for this report believe that the involvement (or lack thereof) of GPs and Primary 
Care Teams impacts Social Prescribing projects in the following ways:
1. Numbers of patients/ individuals referred to Social Prescribing projects.
2. Access to data or information that might help demonstrate the evidence or impact of a 
Social Prescribing project.
It should be noted that time and again during consultations, Link Workers and host organisations recognised 
the enormous pressure and strain on the healthcare system and that the availability of time and resources 
to	explore	or	test	new	ways	of	working	are	sparse.	Projects	also	acknowledged	that	clinical	staff	are	more	




26 Davies, R. (2013). Planning evaluability assessments. a synthesis of the literature with recommendations. DFID Working paper 40. Cambridge, UK: Department for International 
Development
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Currently one RCT is taking place in Ireland (see section 4) which, combined with enhanced evaluation practice 
within Social Prescribing projects, may create the impetus for greater engagement with GPs and PCTs across 
Ireland. The involvement of GP and Primary Care representatives in a follow up to this report is likely to be 
critical.
5.4. SOCIAL PRESCRIBING PROJECTS
The purpose of this report is to present the evaluability capability of existing Social Prescribing projects. This 
assessment is likely to be of use in the following ways:
• The	Evaluation	Index	will	offer	a	reference	point	for	projects	in	terms	of	the	evaluation	and	data	
collection activity associated with a preferred Approach (3) and an aspirational Approach (4).
• The development of a Minimum Data Outcomes Framework (section 8) and the recommendation of 
tools	will	offer	a	structure	within	which	Social	Prescribing	projects	can	design	evaluation.
• The	findings	and	recommendations	from	the	report	may	have	consequences	for	how	funders	view	
evaluation and how they set data collection requirements for projects.
• If a common framework and approach are agreed and implemented, this will provide projects, 
funders and partners with clarity on expected outcomes and the measures used to evaluate such 
outcomes. Such a framework would also allow for a collective review of how Social Prescribing is 
delivered in Ireland (good practice for new projects). It will also support additional lobbying and 
engagement with funders and government departments.
5.5. SLÁINTECARE
Social Prescribing is closely aligned with the HSE’s transformation of the health service model of care under 
Sláintecare, which aims to ensure an integrated model of care based on the principles of ‘Right Care, Right 
Place, Right Time’.
A core objective of Sláintecare is to shift the majority of care from the acute setting to the community - bringing 
‘care closer to home’. Community Healthcare Networks (CHNs) are recognised as the fundamental unit of 
organisation for the delivery of services based on an average population of 5,000. The Sláintecare 
Integration Fund has already funded six Social Prescribing projects across the country, which recognises 
the contribution that	Social	Prescribing	can	offer	to	the	reform	of	the	healthcare	system.
A	Joint	Action	Programme	has	been	formed	between	the	Dept.	of	Health,	Sláintecare	Office	and	the	HSE	
which will set out actions required to develop capacity across acute and community care services, whilst in 
parallel	reducing	bed	demand	by	utilising	existing	capacity	more	effectively,	improving	access	to	a	range	of	
services and improving the health of the population through preventative population measures. Pillar 1 of 
this programme relates to Healthy Living and Social Prescribing is included as a potential key programme 
to be delivered under this workstream. This work will involve developing a framework for the sustainable 
integration of Social Prescribing across the HSE. It also paves the way for the learning and 
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6.1. INTRODUCTION
The checklist below has been taken from pp. 19-23 of: Davies, R., 2013. Planning Evaluability Assessments: A 
Synthesis of the Literature with Recommendations. Report of a study commissioned by the DFID.
The checklist is used to assess evaluability across the three dimensions: Evaluability ‘in principle’, given the 
nature of the project theory of change, Evaluability ‘in practice’, given the availability of relevant data and 
the capacity of management systems able to provide it and the ‘Utility and Practicality’ of an evaluation, 
given the views and availability of relevant stakeholders.
6.2. EVALUABILITY ASSESSMENT
Project Design (as described in a Theory 




Are the long-term impact and 
outcomes	clearly	identified	and	
are the proposed steps towards 
achieving	these	clearly	defined?
Is the project objective clearly 
relevant to the needs of the target 
group,	as	identified	by	any	form	of	
situation analysis, baseline study, 
or other evidence and argument? 
Is	the	intended	beneficiary	group	
clearly	identified?	
Is there a continuous causal chain, 
connecting the intervening agency 
with	the	final	impact	of	concern?
Is it likely that the project objective 
could be achieved, given the 
planned interventions, within the 
project lifespan? Is there evidence 
from elsewhere that it could be 
achieved?
Findings
Social Prescribing projects in Ireland are clear 
about their long term intended impacts and 
result.
Focused on tackling the social determinants of 
ill health, improvements to individual’s wellbeing 
and connectedness can lead to long term 
impacts for Primary Care and health systems. 
The logic model in section 3 sets this out.
The main participant groups accessing the 
projects in this assessment are primarily those 
with mild or long-term mental health problems, 
depression, vulnerable groups (e.g. single 
parents), people who are socially isolated, and 
those who frequently attend either primary or 
secondary health care. 
Delivery	models	differ	across	projects.	The	
project lifespan ranges from short term 1-2 week 
interventions to 6-9 months of engagements 
and spans both a Link Worker and community 
based services, thus outcomes are likely to vary.
Embedding outcome data collection into service 
delivery would evidence this. An RCT is underway 
in Ireland which may provide further evidence, 










Are there valid indicators for 
each expected event (output, 
outcome and impact levels)? i.e. 
will they capture what is expected 
to happen? Are they reliable 
indicators? i.e. will observations by 
different	observers	find	the	same	
thing? 
Is it possible to identify which 
linkages in the causal chain will be 
most critical to the success of the 
project, and thus should be the 
focus of evaluation questions? 
Have assumptions about the 
roles of other actors outside the 
project been made explicit? (both 
enablers and constrainers) Are 
there plausible plans to monitor 
these in any practicable way? 
Is there consistency in the way the 
Theory of Change is described 
across various project multiple 
documents? (Design, M&E plans, 
work plans, progress reports, etc.) 
Are there expected to be 
multiple interactions between 
different	project	components?	






views about the project objectives 
and how they will be achieved? 
How visible are the views of 
stakeholders who might be 
expected	to	have	different	views?
There	are	no	defined	indicators	for	Social	
Prescribing projects in Ireland. Projects would 
benefit	from	structured	guidance	around	what	to	
measure and how to measure it. 
The exchange between the Link Worker and the 
participant appears to be the most important 
transaction in the causal chain.
The roles of Primary Care Teams as referrers and 
C&V organisations as service delivery agents have 
been	identified	and	are	understood.	Depending	
on the requirements of funders, evaluation may 
require each of these actors to participate through 
the provision of data or contribution of insights.
Many of the projects are in their infancy. The 
majority	do	not	have	a	defined	theory	of	change	
for their project; however, this assessment 
has developed a common theory of change 
framework for projects. 
Despite	multiple	interactions	with	different	
providers,	these	are	clearly	defined	and	can	be	
set out in stages and are not complicated. It is 
potentially	difficult	to	isolate	the	effects	of	one	
component compared to another.
Stakeholders have demonstrated a consistent 
understanding of the purpose and objectives of 
Social Prescribing. More than 280 people have 
contributed to the evaluability assessment and 
Minimum Data Outcomes Framework. Some 
differences in opinion exist in the nature of the 
referral, these views are recognised in the framework.











Is there data 




for all the 
indicators?
Are they relative to what could 
have been expected? E.g. Project 
proposal, Progress Reports, 
Evaluations / impact 
assessments, Commissioned 
studies
If baseline data is not yet available, 
are	there	specific	plans	for	when	
baseline data would be collected 
and how feasible are these?
If baseline data exists in the form 
of survey data, is the raw data 
available, or just selected currently 
relevant items? Is the sampling 
process clear? Are the survey 
instruments available?
If baseline data is in the form of 
national or subnational statistics, 
how disaggregated is the data? 
Are time series data available, for 
pre-project years? 
Is it clear how the control group 
compares to the intervention 
group? Is the raw data available 
or just summary statistics? Are 
the members of the control 
group	identifiable	and	potentially	
contactable? How frequently has 
data been collected on the status 
of the control group?
Is	it	with	sufficient	frequency?	Is	
there	significant	missing	data?	Are	
the measures being used reliable 
i.e. Is measurement error likely to 
be a problem?
Findings
The assessment has considered twelve 
projects. Complete set of documents and data 
are available for circa four of the twelve projects. 
The others are in early stages of evaluation and 
contain complete sets of output data, but are 
reliant on anecdotal case studies as the primary 
evidence/impact source. 
Baseline data exists in around 60% of projects,  
this comes in the form of validated tools such as 
SWEMWBS, WHO-5, HADS, MyCAW.
The other projects do not have baseline data 
available, however it is feasible to gather baseline 
data, embedded into service delivery, with some 
support,	resources	and	capacity	building	for	staff.
There is an RCT taking place in Ireland currently 
which will provide access to data on a comparison 
group.
Reliable measures are used in 60% of the 
projects.	These	are	collected	with	sufficient	
frequency and three projects are subject to 
external	evaluation	and	verification.	The	others	
are characterised by anecdotal and qualitative 




















Are the intended and actual 
beneficiaries	identifiable?	Is	there	
a record of who was involved in 
what project activities and when? 
In the baseline? For each of 
the indicators during project 
intervention? In the control 
group? In any mid-term or process 
review? 
Are the reports available? Are the 
authors contactable? Is the raw 
data available? Is the sampling 
process clear? Are the survey 
instruments available? 
Where data is not yet available, 
do	existing	staff	and	systems	
have the capacity to do so in 
the future? Are responsibilities, 
sources	and	periodicities	defined	
and appropriate? Is the budget 
adequate?




All projects can provide breakdown of participants 
by gender. In those projects that are using reliable 
tools, disaggregated data should be available. 
Of the twelve projects engaged, three have been 
subject to independent and external evaluation. 
The reports are available (two are still ongoing) 








Are there physical security risks? 
Will weather be a constraint?
Are	staff	and	key	stakeholders	
likely to be present, or absent 
on leave or secondment? Can 
reported availability be relied 
upon?
There are limitations to existing monitoring & 
evaluation systems including: capacity (skills and 
time) of Link Workers, resources (limited funding), 
systems (use of excel etc – only 25% of projects 
are using purpose built digital systems).
Findings
This report has been developed during the 
COVID-19 global pandemic which will impact the 
launch	and	dissemination	of	findings.	
There is strong buy in and willingness to consider 
new approaches across statutory, Primary Care 
and C&V networks. At a recent conference 
(December 2019), the Minister of State for 
Mental	Health	offered	a	strong	statement	and	
commitment of support for Social Prescribing.














Time available in total and in 
country? Timing within the 
schedule of all other activities? 
Funding available for the relevant 
team and duration? People with 
the necessary skills available at 
this point? 
Is there an opportunity for an 
evaluation	to	have	an	influence?	
Has the project accumulated 
enough implementation 
experience to enable useful 
lessons to be extracted? If the 
evaluation was planned in advance, 
is the evaluation still relevant?
How many other donors, 
government departments, or 
NGOs need to be or want to 
be involved? What forms of 
coordination are possible and/or 
required? 
Have the primary users been 
clearly	identified?	Can	they	be
involved	in	defining	the	evaluation?	
Will they participate in an 
evaluation process? 
The availability of funding and the time available 
to projects is a constraint. Most projects operate 
with part time Link Workers (12-24 hours per 
week). Most projects report operating at a loss 
and majority of Link Workers reported a need 
for capacity building and support in relation to 
evaluation. 
There is an opportunity for evaluation to 
influence.	The	Department	of	Health	has	
launched a new €20m Sláintecare fund and have 
supported a number of new projects. Social 
Prescribing is referenced in the new Mental 
Health Strategy, Sharing the Vision. There is a 
growing momentum around the All-Ireland Social 
Prescribing Network and a recognition beyond 
health that the projects may deliver positive 
outcomes. 
The	assessment	has	identified	multiple	outcomes	
that move beyond health. There is merit in the 
project promoters (HSE and Department for 
Health) widening the discussion to include those 
responsible for housing, employment, skills and 
welfare, given the apparent impact in these areas. 
There is a clear desire for evaluation and 
enhanced evaluation practice. The development 
of a Minimum Data Outcomes Framework has 
generated	significant	interest.	Those	with	an	
interest include: HSE, Department of Health, 
Primary Care Networks, C&V organisations such 















What evaluation questions are 
of interest to whom? Are these 
realistic, given the project design 
and likely data availability? Can 
they be prioritised? How do 
people want to see the results 
used? Is this realistic? 
What designs do stakeholders 
express interest in? Could 
these work given evaluation the 
questions of interest and likely 
information availability, and 
resources available? 
Are they known or knowable? 
Are they likely to be manageable? 
What constraints will they impose?
Will stakeholders be able to 
manage	negative	findings?	Have	
previous evaluation experiences 




• Does social prescribing work for participants?
• Does	it	reduce	pressure	and	enhance	efficiency
within Primary Care?
• Is it value for money?
C&V Organisations
• How can we validate outcomes?
• How can delivery models be improved to
maximise outcomes?
• What do we need to measure & evidence to
secure longer term funding? 
Given the nature of the projects, stakeholders 
are concerned that evaluation could subsume 
the intervention. Any tools used should be short 
and straightforward to administer. Stakeholders 
also report an interest in digital approaches that 
simplify and streamline evaluation across projects 
and	enable	shared	learning	and	reflection.	
Ethical issues relating to Social Prescribing 
(vulnerable groups, data transfer, data storage) all 
create constraints, but it is possible to overcome 
them through correct procedure and adherence to 
ethical guidelines and data protection legislation. 
Where appropriate, stakeholders have responded 
to previous evaluations in a constructive manner 
and have used the evidence to make changes 
to projects. Stakeholders all recognise the 
importance of evaluation and have demonstrated 
a willingness to take part.
Utility Findings
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Key Finding 
The evaluability assessment demonstrates that Social Prescribing can be evaluated.
There are a number of enabling factors that the HSE and other partners can support to get to this 
point. A programme of support for projects to ensure the implementation of quality evaluation 
practice,	aligned	to	 the	clarified	expectations	of	 funders	would	 increase	the	potential	 for	 reliable	
evaluation. The nature of this support is set out in recommendation 3. It is anticipated that this would 
lead	to	the	effective	evaluation	of	individual	projects,	as	well	as	in	the	longer	term,	the	potential	for	a	
national evaluation of Social Prescribing projects in Ireland.
6.3 SUMMARY
The outputs from the checklist are an assessment of the evaluability of Social Prescribing in Ireland and the 
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7.1. INTRODUCTION
Despite some projects existing for several years, Social Prescribing remains somewhat in its infancy in 
Ireland in comparison with other areas, notably the UK. The experience of the research team (Elemental in 
particular) enables several lessons to be learned from existing practice in the UK, and thus applied to this 
report and its recommendations.
In the UK, Social Prescribing reaches across all health and wellbeing domains, health, local government, the 
voluntary, community and social enterprise sector, charities and private organisations and housing 
associations. One of the big challenges for those working in Social Prescribing is connecting these systems 
together, or perhaps rather the information within them, to achieve optimal outcomes for the populations 
and communities they support.
There are a number of national policy drivers in the UK which have enabled the growth of Social Prescribing 
and which have supported health and social care communities to work together, understand each other’s 
pressures, challenges and opportunities, and in a more joined up way, service their population. For the NHS 
and Local Authorities, this has been driven through the Sustainability and Transformation Partnerships 
(STPs), which bring together health organisations from all sectors, often including local government, to co-
ordinate health and wellbeing across regions. Whilst this potentially has more relevance for implementation 
than	evaluation,	efforts	have	been	made	to	provide	guidance	on	outcomes,	indicators	and	evaluation	here.
Other initiatives/ policies and frameworks are outlined below:
7.2. NHS LONG TERM PLAN 
Social Prescribing is a key component of Universal Personalised Care. A summary guide27 has been 
developed for people and organisations leading local implementation of Social Prescribing. It sets out 
what good Social Prescribing looks like and why Social Prescribing improves outcomes and experiences for 
people, their families and carers, as well as achieving more value from the system.
7.3. PRIMARY CARE NETWORKS28
To meet the needs of an ageing population, in England, GP practices work together and with community, 
mental health, social care, pharmacy, hospital and voluntary services in their local areas in Primary Care 
Networks (PCNs). PCNs are a key part of the NHS Long Term Plan, with general practices a core part of a 
network, typically covering 30,000-50,000 patients. The networks will provide the structure and funding 
for services to be developed locally, in response to the needs of the patients they serve. Over 1,000 Link 
Workers have been funded by the NHS29 to support Primary Care to better connect their patients with 




PCNs enable greater provision of proactive, personalised, coordinated and more integrated health and 
social care. GPs and other Primary Care professionals describe this as a change from reactively providing 
appointments, to proactively caring for the people and communities they serve. 
7.4. QU
PRESCRIBING30
ALITY ASSURANCE FRAMEWORK FOR SOCIAL
The Quality Assurance Framework for Social Prescribing has been developed to support the ongoing 
evolution of Social Prescribing in England, where it is estimated that 60% of Clinical Commissioning Groups 
are investing in Social Prescribing.
The work programme was led by Craig Lister (Managing Director of TCV’s Green Gym). This was 
supported by an Advisory Panel and involved extensive consultation and engagement with a wide 
range of stakeholders. The Royal Society for Public Health has endorsed the Framework. The work 
programme was funded by the National Lottery Community Fund and is available to projects in Ireland as 
a resource.
7.5. COMMON OUTCOMES FRAMEWORK31
NHS England has developed a Common Outcomes Framework for Social Prescribing. This is 
contained within ‘The Social Prescribing and Community-based Support – Summary Guide’ released 
in January 2019. The summary guide has been developed to support organisations leading the local 
implementation of Social Prescribing. The Common Outcomes Framework recognises the clear 
need for a common approach to documenting the impact of Social Prescribing schemes and aims 
to capture core data to create a consistent evidence base of its impact. The framework is a work in 
progress document and will be further augmented as Social Prescribing continues to evolve and 
develop. The framework suggests that the impact of Social Prescribing covers three key areas:
• Impact on the person
• Impact on community groups
• Impact on the health and care system.
30https://42b7de07-529d-4774-b3e1-225090d531bd.filesusr.com/ugd/14f499_a5e3a40ac260401a80e01853bb7ef8b9.pdf
31https://www.england.nhs.uk/wp-content/uploads/2019/01/social-prescribing-community-based-support-summary-guide.pdf Page 28
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7.5.1. Impact on the Person
The framework recognises that a variety of tools are being used by existing projects to capture this impact. 
The	framework	anticipates	that,	depending	on	the	needs	identified,	one	or	more	aspects	of	wellbeing	will	
be improved as the person:
• Feels more in control and able to manage their own health and wellbeing
• Is more physically active
• Is better able to manage practical issues, such as debt, housing and mobility
• Is more connected to others and less isolated or less lonely.
The measurement tools include:
• Patient Activation Measure
• Office	National	Statistics	(Personal	Wellbeing	Questions)
• Short Warwick-Edinburgh Mental  Wellbeing Scale.
7.5.2. Impact on Community Groups
The	 authors	 of	 the	 framework	will	 co-produce	 and	 test	 a	 freely	 available	 short	 confidence	 survey	 for	
community groups about the impact of taking Social Prescribing referrals. This survey will test the resilience 
of community groups as a result of their involvement in Social Prescribing. Areas to be examined will include:
• Changes in the number of volunteers
• Capacity of the voluntary sector to manage referrals
• Support needed to make Social Prescribing sustainable.
7.5.3. Impact on the Health and Social Care System
The framework advises that Social Prescribing schemes should collect data on the change in the following 
(as a result of referral to Social Prescribing):
• Number of GP consultations
• A&E attendance
• Number of hospital bed days
• Volume of medication prescribed
• Morale	of	staff	in	general	practice	and	other	referral	agencies.
The authors of the framework will support the development of robust data sharing agreements to collect 
the above data.
The framework also highlights 3 SNOMED CT terms that have been established for Social Prescribing in GP 
IT systems: 
• 871691000000100	|	Social	Prescribing	offered	(finding)
• 871711000000103 | Social Prescribing declined (situation)
• 871731000000106 | Referral to Social Prescribing service (procedure).
The availability of resources such as surveys, data sharing agreements and measure indicators are of 




and Local Authorities to drive shared care records, join up the sharing of data and systems for patients and 
citizens and to include other organisations in this work. In Ireland this may include an exploration of digital 
options for projects, Primary Care Networks and funders to enhance the consistency and congruence of 
impact data for Social Prescribing.
7.7. EXISTING EVALUATIONS
Whilst there has been criticism of evaluation approaches in the UK32, there are several examples of 
independent	evaluations	that	offer	a	basis	for	projects	in	Ireland	to	explore	and	utilise	as	a	framework.
One	example	 is	 a	 short	 report	 (2018)	 on	 the	 findings	of	 an	 independent	 evaluation	by	 researchers	 at	
Sheffield	Hallam	University	with	expertise	in	Social	Prescribing33.	It	covered	the	first	9	months	of	the	Hale	
Community Connectors Social Prescribing service (March-November 2017) and aimed to answer some key 
questions about the Community Connectors Social Prescribing Service to support future commissioning 
by the Clinical Commissioning Group and its partners. In addition, an Evaluability Assessment was published 
recently34 providing a review of the research methods and approaches used to evaluate UK-based Social 
Prescribing interventions in recent years, to inform healthcare and social services professionals, as well as 
organisations delivering Social Prescribing interventions and those conducting evaluations. It aims to give 
an overview of how Social Prescribing has been evaluated, and, importantly, what can be learned from this.
The development of a platform or channel to share evaluation resources has been explored in England and 
may	be	of	benefit	to	Social	Prescribing	projects	in	Ireland.
32 Bickerdike L, Booth A, Wilson PM, et al. Social Prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7(4)
33EvaluationofHaleCommunityConnectorsSocial PrescribingService2017 [PDF]Source:SocialCareCollection -01February2018-Publisher: Sheffield	Hallam	University.	Centre	
for Regional Economic and Social Research
34 https://www.iriss.org.uk/resources/insights/evaluation-social-prescribing
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8.1. INTRODUCTION
One of the objectives of this report was to develop a Minimum Data Outcomes Framework 
for Social Prescribing projects in Ireland, using a consensus-based methodology, and 
provide recommendations on how to establish a system to collate and report on outcomes 
nationally. The outcomes framework outlined below sets out which outcomes should be measured, and 
which tools can be used to measure them. This is designed to be a practical and implementable tool for 
projects to assist with evaluation design, and is not a guide on how to carry out evaluation.
8.2. ASSUMPTIONS
The framework is focused on outcomes; which are underpinned by two key assumptions:
• 
• 
All projects will continue to collate administrative data including, but not limited to, number, nature 
and	source	of	referral,	number	and	profile	of	participants,	number	of	meetings	and	number	of	
onward referrals (see appendix 4 for sample participant form).
All projects will continue to record participant stories/testimonials to highlight the personal and 
human impact of their work. This may be the role of an independent evaluator depending on the 
nature of evaluation in each project.
The Minimum Data Outcomes Framework represents a starting point for Social Prescribing projects in 
Ireland. Approaches to evaluation will align to the objectives of evaluation for each project. Projects should 
move beyond the minimum outcomes if it is within their scope, resources, or capacity to do so.
8.3. DEVELOPING THE MINIMUM DATA OUTCOMES FRAMEWORK
In	order	 to	develop	the	 framework,	 the	 researchers	firstly	established	a	 long	 list	of	outcomes	that	are	
currently being reported by projects in Ireland. The outcomes are categorised in a similar way to the NHS 
Common Outcomes Framework, that is:
• Participant Outcomes (The patient, the citizen, the resident)
• System Outcomes (The health and social care system)












• Enhanced self esteem
• Enhanced mental wellbeing
• Increased independence






• Reduced suicide ideation
• Increased sense of feeling
connected
• Increased levels of
volunteering
• Increased Income - relating
to	increased	benefits/
employment
• Enhanced sustainability of 
housing tenancies
• Enhanced skills and 
qualifications








• Reduction in the number of GP 
appointments
• Reduced pressure on GPs or
Primary	Care	staff
• Reduction in the number of ED 
admissions
• More appropriate 
management and use of 
Prescription medication




•  Increased understanding 
and awareness of available
services
•  Increased partnership
working





8.4. PRIORITISING AND SHORTLISTING OUTCOMES
A co-design workshop was organised and facilitated by the researchers on 6th March 2020. The workshop 
was attended by 24 individuals representing Social Prescribing projects, community and voluntary 
organisations and funders/statutory organisations across Ireland.
The purpose of the workshop was to shortlist and prioritise the outcomes that MUST be measured within 
a Minimum Data Outcomes Framework. Participants were divided into small working groups of 4-5, each 
group	was	asked	to	complete	the	framework	(below)	and	feedback.	The	findings	have	directly	informed	the	
Minimum Data Outcomes to be measured by Social Prescribing projects across Ireland.
Image 2: Tool used during co-design 
workshop to prioritise and shortlist 
outcomes
The centre of the framework relates to those outcomes that participants consider ‘MUST’ be 
measured. Each group was provided with the long list of outcomes (section 8.3) and asked to 
prioritise the outcomes that cut across all Social Prescribing projects and therefore should be the central 
pillars of any Minimum Data Outcomes Framework. These are the primary focus in this report.
Arguably all and any outcomes achieved are important to measure. However, in light of the factors impinging 
on evaluation currently in Ireland, the Minimum Data Outcomes Framework represents a starting point.
The middle and outer rings in the framework relates to those outcomes that ‘Should’ be measured and 
those that ‘Could’ be measured. It was acknowledged that these may change on a project by project, and 
participant by participant basis – but would represent outcomes that stakeholders felt were important to 
capture within an evaluation of Social Prescribing.




between what could and what should be measured.
The tool will be useful for individual projects developing an evaluation approach and identifying outcomes 
beyond the ‘minimum outcomes’.
8.5. MINIMUM OUTCOMES FRAMEWORK
The results of the workshop are presented in tabular format below:
Participant
Outcomes
• Change in personal
wellbeing
• Change in social 
connectedness / social
wellbeing (see appendix 3 for
further details)
Dependent on 
participants, projects and 
funder expectations and 






• Resilience and coping
skills
• Change in income - 
relating	to	benefits	or
employment status
• Sustainability of housing
tenancies





• Reduction in pressure 
on GPs and Primary Care
Teams
• Change in mental health
waiting list














• Improved access to
services
• Increased number of
volunteers
• Enhanced	confidence,	
feeling valued and 













management and use of
Prescription medication
• Reduced Length of
hospital stays
• Reduced Emergency 
Department admissions





What the services are 
that are now available/
who are they for, and 




The	 co-design	 workshops	 identified	 consistently	 that	 personal	 wellbeing	 and	 social	 connectedness/
wellbeing	were	 the	 two	critical outcomes that must be measured within a Social Prescribing project. 
Both outcomes relate to the participant.
Measuring both outcomes will require the use of validated tools, implemented at initial assessment and 
at agreed intervals. Link Workers suggested that a maximum of two validated questionnaires could be 
administered during assessments with participants. Feedback suggested that these could be administered 
in	 a	 subtle	 or	 conversational	way	 (although	 this	may	 have	 implications	 for	 the	 validity	 of	 findings	 and	
comparison of projects).
A number of validated tools to measure wellbeing and social connectedness are set out below as well as the 
rationale and process for selecting the particular tools:
• Tools that are free to use – Social Prescribing projects have limited resources, therefore reducing 
the cost of implementing enhanced evaluation practice was important.
• Tools that are implementable and can be embedded into service delivery –  a key recommendation 
from Link Workers was that tools should be straightforward to administer and where possible, 
short in length. The ‘informal’ and non-clinical nature of the intervention was cited as important by 
at least nine of the Social Prescribing projects consulted. Concerns were raised about the use of 
long or complex evaluation tools and the risk that their administration could ‘subsume the 
intervention’.
• Tools that were already in use – where validated tools were already in use, it makes sense to try to 
ensure continuity.
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8.6. TOOLS TO MEASURE PERSONAL WELLBEING
The following tools are suggested as being appropriate to measure change in personal wellbeing (The 
researchers	 acknowledge	 that	many	 other	 tools	 exist	 and	 are	 likely	 to	 be	 effective	 in	measuring	 the	
minimum outcomes for Social Prescribing).
• The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS)35
SWEMWBS	is	a	scale	of	seven	positively	worded	items,	with	five	response	categories,	designed	
to measure both the feeling and functioning aspects of positive mental wellbeing. The SWEMWBS 
is a shortened version of the longer Warwick and Edinburgh Mental Wellbeing Scale (WEMWBS). 
Warwick and Edinburgh Universities were commissioned to develop this in 2006, and it has been 
academically validated as having good psychometric properties, good validity and reliability with 
the ability to distinguish between population groups. It is widely used in population surveys in the 
UK and elsewhere, including in the Health Survey for England in 2011. Note that permission must be
sought for use of the measure, although it is free to use.
• World Health Organisation Five Wellbeing Index (WHO 5)
WHO-5 is a short self-reported measure of current mental wellbeing. The WHO-5 demonstrates 
validity in screening for depression and in measuring wellbeing outcomes in clinical trials. The WHO-
5 is free of charge and does not require permission to use and it is already being used by a number 
of Social Prescribing projects in Ireland.36
8.7. TOOLS TO MEASURE SOCIAL CONNECTEDNESS/SOCIAL
WELLBEING
The following tools are suggested as being appropriate to measure change in social connectedness/social 
wellbeing.
• Revised Social Connectedness Scale37.
This scale assesses the degree to which people feel connected to others in their social environment.
The original scale included 8 items but was revised to include a list of 20 items on a 6-point Likert 
scale ranging from 1 (strongly disagree) to 6 (strongly agree). The additional 12 items were inserted 
to combat the limitations of negative wording of the original 8. Items are summed; a higher score 
indicates more connectedness to others. Many studies still use the original 8 items for social 
connectedness, this may be more practical for Social Prescribing projects. Permission is required 
from the author before use.
• Social Wellbeing Scales38
This	scale	consists	of	33	items	organised	in	five	dimensions	measuring;
• individual’s sense of belongingness (i.e., social integration)
• sense of value to society (i.e., social contribution)
• sensibility and meaningfulness of the social world (i.e., social coherence)
• sense of potential for continued growth in social institutions and society (i.e., social
actualization) and
• one’s degree of comfort and acceptance of other people (i.e., social acceptance).
35 http://www.healthscotland.com/understanding/population/ Measuringpositive-mental-health.aspx 
36https://www.corc.uk.net/outcome-experience-measures/the-world-health-organisation-five-wellbeing-index-who-5/	
37 Lee, R. M., Draper, M., & Lee, S. (2001). Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: Testing a mediator model. Journal of Counseling 
Psychology, 48(3), 310–318
Each dimension contains 6 or 7 items through a Likert scale from 1 to 7 (from Strongly Disagree to Strongly 
Agree) by which participants are asked to rate their degree of social wellbeing. Higher scores mean that 
socially healthier people should not see society as unpleasant and see themselves as important members. 
They should care about, and feel safe, in the community, living a coherent life. This scale may be too long 
although it is unclear whether the scale can be adapted and some of the individual dimensions used 
separately. The scale is free to use but permission must to be sought from the author.
8.8. CAPTURING CONTRIBUTION OF LINK WORKERS
Participants in the co-design workshop (and throughout the evaluability assessment) discussed the 
challenges of attribution and the importance of capturing the contribution or role of the Link Worker within 
any Minimum Data Outcomes Framework.
As referenced previously in this report, the ‘feasibility of attribution’, i.e. establishing the causal 
relationship between the Link Worker and a positive outcome (where one exists) is likely to be a 
challenge for future evaluation of Social Prescribing projects. The use of qualitative tools, such as case 
studies, are likely to be the most appropriate method of capturing contribution. Case studies can be 
carried out by independent evaluators, and examples of case studies for participants can be found in 
Evaluation of the Rotherham Social Prescribing Project39 and the Richmond CCG Social Prescribing 
Project40.
Other	 tools	 such	 as	 the	 Most	 Significant	 Change	 (MSC)	 technique41 can be used to help assess 
the performance	 of	 the	 initiative	 as	 a	 whole.	 Essentially,	 this	 process	 involves	 the	 collection	 of	 a	
significant	change (SC) story using one validated question. In the case of Social Prescribing projects, 
this technique would	 be	 applied	 at	 the	 end	of	 an	 engagement	with	 an	 individual	 to	 identify	 the	most	
significant	 change	 following that intervention. These tools are likely to be more appropriate for the 
independent evaluation of projects.
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8.9. MINIMUM DATA OUTCOMES FRAMEWORK APPLIED
The following diagram presents a summarised version of the Social Prescribing process. It is intended 
that this process creates a positive change for each participant who moves through it in respect of their 
wellbeing	and	social	connectedness.	This	in	turn	can	contribute	to	a	host	of	other	benefits	for	the	participant	
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The following sets out the implications for Social Prescribing practitioners and evaluators in applying the 
Minimum	Data	Outcomes	Framework.	We	acknowledge	that	projects	are	operating	with	different	models,	
resources, and capacity. In some cases, Link Workers will inevitably implement some of this work (which is 
verified	externally	at	the	end	of	project)	and	in	others	this	may	be	the	role	of	independent	evaluators.
8.9.1.Step 1 – Establishing Tools
Social Prescribing projects to establish a suite of data collection and measurement tools that collectively 
make up their evaluation framework. These include (examples of tools have been provided in the report 
and at appendices):
• Quantitative	Participant	Profile	(template	in	appendix	4)
• Validated tool to measure personal wellbeing (2 examples are suggested)
• Validated tool to measure social connectedness (2 examples are suggested)
• Case Study Template (references to sample case studies in Rotherham and Richmond CCG Social
Prescribing Evaluations)
• Survey for community and voluntary organisations (sample being developed in NHS 
Common Outcomes Framework)
• Survey for Primary Care Teams (template in appendix 5)
• System for storing all data.
8.9.2. Step 2 – Gathering baseline and ‘pre’ data as part of service delivery
Social Prescribing projects to gather participant profile data on all participants as well as baseline 
data on personal wellbeing and social connectedness using one of the recommended tools. The use 
of samples for the validated evaluation tools (e.g. 30% or 1 in 3) may be a more appropriate approach for 
projects with limited resources. This may equate to 20-30 participants per annum.
The	baseline	or	‘pre’	data	is	usually	gathered	at	first	engagement	with	the	participant.	The	initial	engagement	
with	a	Link	Worker	is	often	therapeutic	in	nature	and	therefore	may	influence	baseline	data.	Projects	should	
consider how best to gather participant data at the outset to enable any change to be measured.
8.9.3. Step 3 – Gathering follow up and ‘post’ data as part of service delivery
Follow up and ‘post’ data to be collected at specified intervals (at 6 weeks, 8 weeks, 12 weeks and/or 
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8.9.4. Step 4 – Stakeholder Engagement
As part of a longer term approach to evaluation, semi-structured interviews or case studies capturing 
a participant story to be recorded to complement data gathered using validated tools. This data 
collection is typically the role of an independent evaluator. In addition, SP projects could seek to issue 
surveys to Primary Care Teams and C&V organisations on an annual basis to assess the impact of its work. 
The surveys can be issued directly by the projects or by an independent evaluator.
8.9.5. Step 5 – Making use of data
Data to be collected by projects as part of service delivery and handed over to independent evaluators 
at the end of a project for verification.	Data	and	findings	should	be	analysed	to	identify	outcomes	and	
impacts (if any) and inform service developments and improvements.
8.9.6. Step 6– Sharing and Communicating Findings
Social Prescribing Projects to communicate findings to participants, funders, stakeholder organisations 
and collectively within the network to share and embed learning. The use of infographics and impact 




S3 Solutions and Elemental were delighted to undertake this evaluability assessment and contribute to 
building the capacity for the evaluation of Social Prescribing in the Republic of Ireland.
The objectives of this project were, to undertake an evaluability assessment of Social Prescribing 
projects in Ireland by:
This report is framed around the three dimensions of Evaluability Assessment42, including:
              a  Evaluability in principle (i.e. clarity of the intervention and its theory of change)
              b  Evaluability in practice (i.e. what data are available and what systems are in place to provide these 
 data)
              c  Evaluability	usefulness	(i.e.	what	interest	do	stakeholders	have	in	using	evaluation	findings	for	
example, to enable strategic decision making).
9.2. KEY FINDINGS
Summary	findings	from	the	evaluability	assessment	are	outlined	below;.
• Social Prescribing is growing in Ireland, there are now in the region of 18-20 funded projects and 
the All-Island Social Prescribing Network  continues to expand. At a recent conference, delegates 
and speakers consistently referred to the Social Prescribing ‘movement’. Based on the 
researcher’s observation, the commitment to, and advocacy of Social Prescribing was profound.
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42 Davies, R. (2013). Planning evaluability assessments. a synthesis of the literature with recommendations. DFID Working paper 40. Cambridge, UK: Department for International 
Development
• The theory of change for Social Prescribing projects in Ireland is clear and logical, and the 
measurement of intended outcomes at an individual level are achievable using reliable and valid
tools.
• Those interviewed in this evaluability assessment believe that the Link Worker is the most important
component in the causal chain – or the key mechanism for change. The skill set, capacity and 
competencies of the Link Worker are therefore crucial.
• Measuring the longer term impacts of Social Prescribing (i.e. reduction in public health sector costs 
and pressures) requires the participation of Primary Care Teams and other parts of the health 
system, both in the referral of participants and in the provision of data to enable analysis. This is 
likely	to	be	a	challenge.	Early	indications	from	one	project	identified	significant	reductions	in	mental	
health waiting lists. If the system level data was gathered systematically and rigorously this could be
used as the entry point to engage further Primary Care networks.
• One of the key areas of challenge relates to the availability of outcomes data. This means that 
evidencing the outcomes of most Social Prescribing projects in a reliable way, is not possible without
additional data collection. To enable additional data collection, evaluation capacity building activities 
are required as well as a commitment to and investment in, embedding data collection into service 





organisations that are delivering projects and from the All-Island Social Prescribing Network, but 
also from the HSE, Department of Health and many Primary Care professionals. There is an 
opportunity to harness this interest to generate a momentum around evaluation and secure 
greater participation from relevant stakeholders.
Existing evaluation practice varies greatly across Ireland. S3 Solutions and Elemental devised 
an Evaluation Index to capture and frame existing practice. Whilst the majority of groups are 
operating at ‘Approaches 1-3’, stakeholders agreed collectively that ‘Approach 3’ is preferred 
(including independent evaluation) with ‘Approach 4’ representing the ideal or aspirational level of 
evaluation.
• The	purpose	and	use	for	evaluation	differ	per	stakeholder.	For	projects,	ensuring	that	
outcomes	are being achieved for participants, service improvement and funding security are of 
primary concern,	in	which	case	EI	Approaches	2-3	may	be	sufficient.	For	funders	and	PCTs,	
value	for	money and resource savings may be a priority and therefore Approaches 3-4 may be 
essential. Clarity in terms of what is expected from evaluation by funders may assist projects 
with evaluation design and implementation.
1. Providing an overview and synthesis of current Social Prescribing services and programmes
in Ireland in terms of the underlying theory of change and programme logic models.
2. Assessing the capacity of the current Social Prescribing system in Ireland to collect process, 
output and outcome data to support impact evaluation.
3. Developing a Minimum Data Outcomes Framework for Social Prescribing services in Ireland, 
using a consensus-based methodology, and providing recommendations on how to establish 
a system to collate and report on outcomes nationally.
•  An evaluability assessment was an appropriate approach by the HSE. Social Prescribing can be 
evaluated, and outcome data collection can be embedded in service delivery. However, a number 
of enabling factors and steps can be taken to enhance the availability of evidence which potentially 
could lead to a national evaluation of Social Prescribing in the future.
• Many lessons can be learned from elsewhere, particularly the work of the NHS UK, relating to 
outcomes frameworks, quality assurance frameworks, partnership working with Primary Care 
Teams, template evaluations and data collection tools.
• A Minimum Data Outcomes Framework has been developed comprising two core outcomes 
to be measured at an individual level: personal wellbeing and social connectedness. These are 




• There are a wide range of organisations and sectors with a stake in Social Prescribing and its 
evolution and development will require collective action and partnership working. This is not 
limited to the organisations delivering projects or those involved in direct health care provision. 
There is merit in a cross sector, cross departmental approach to explore how Social Prescribing 
can evolve with	evaluation	and	evidence	at	its	core.	The	Minimum	Data	Outcomes	Framework	
may	be	the	first	step in this process.
9.3. CONCLUDING THOUGHTS
The	report	demonstrates	 that	Social	Prescribing	can	be	evaluated.	 It	offers	a	 foundation	 in	 terms	of	a	
common approach to outcomes which promotes consistency and coherence for practitioners and funders 
alike	and	can	be	refined	as	investment	and	delivery	of	Social	Prescribing	continues	to	develop	in	Ireland.	The	
Minimum	Data	Outcomes	Framework	offers	a	solid	starting	point	for	the	evaluation	of	Social	Prescribing	
projects and should evolve alongside the evolution of funding, projects and other research.
9.4. RECOMMENDATIONS
The following 5 recommendations are set out to enable the growth of good quality evaluation of Social 
Prescribing. The majority of recommendations fall within the remit of the HSE as project promoters – 
however it is envisaged that a collaborative approach involving all relevant stakeholders will be required.
9.4.1. Recommendation 1
Ireland’s General Practice is under pressure. The Primary Care system is busy, overstretched and not 
always responsive to change. Ireland boasts, however, a network of champion GPs and via Sláintecare is 
entering a period of change, including the introduction of new data systems and new ways of distributing 
and allocating resources.
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To progress the Minimum Data Outcomes Framework, it should be tested further with relevant 
stakeholders. This	 research	 process	 has	 included	 significant	 engagement	 from	 the	 C&V	 sector	 and	
feedback	 from	Primary	Care	professionals	but	the	outbreak	of	COVID-19	restricted	PCT	participation	in	
the	final	stages	and	thus	the	development	of	the	framework	would	benefit	from	further	engagement	and	
consensus	from	the Primary Care community.
It is recommended that the HSE, supported by champion GPs, facilitate a number of engagement 
events with a network of GPs and Primary Care professionals. The focus of this engagement should be 
centred on a number of key questions:
              a  If projects implement the Minimum Data Outcomes Framework and can demonstrate positive 
outcomes in wellbeing and social connectedness using validated tools – to what extent will this 
strengthen your view on Social Prescribing and likelihood of participating in Social Prescribing 
 projects?
              b  Approach 4 of the EI requires access to data relating to waiting lists, GP attendance etc. What can 
projects, via independent evaluations practically do to access this data to support evaluation 
efforts?
              c  What additional information, beyond that included in the Minimum Data Outcomes Framework 
would encourage greater PCT involvement in Social Prescribing projects? 
9.4.2. Recommendation 2
The HSE (Health and Wellbeing & NOSP), The Department of Health (Sláintecare) and Healthy Ireland are 
currently the main funders of Social Prescribing projects in Ireland. 
Given the apparent impact on areas beyond health, it is recommended that the HSE as commissioners 
of this report, utilise the findings to stimulate engagement with other government departments, 
funders, commissioners and statutory bodies including but not limited to housing, employment and 
skills and welfare. The focus of this engagement should be centred on a number of key questions:
              a  To what extent does the proposed Minimum Data Outcomes Framework, if implemented 
appropriately by projects, satisfy funders and commissioners of the merits of Social Prescribing?
              b  What additional information, beyond that included in the Minimum Data Outcomes Framework 
would encourage a more sustainable funding approach in Social Prescribing projects?
A roundtable discussion about how best departments can work together to contribute to enhanced 
evaluation	efforts	may	enable	a	more	streamlined	delivery	of	other	recommendations.
9.4.3. Recommendation 3
This report has highlighted that whilst evaluation of Social Prescribing projects is possible, for many 
projects,	 there	 is	 insufficient	 valid	 and	 reliable	 data	 collection,	 not	 to	 mention	 resources,	 to	 merit	
commissioning their own evaluations. It is recommended that the HSE and other partners (listed above) 
consider implementing a 12 month programme of support to Social Prescribing projects to implement 
evaluation. This may include:
• Securing permission to utilise validated tools by contacting authors where necessary on behalf of 
Social Prescribing projects.
• Providing practical support to implement the Minimum Data Outcomes Framework including 
support to access and utilise the recommended tools and resources. This could include the 
development and dissemination of the Minimum Data Outcomes Framework as a toolkit/resource
and online or workshop based support for projects.
• Providing resources to assist with data collection, data storage and data analysis. This can include 
financial	resources	to	enable	projects	to	source	support	(i.e.	part	time	administration	shared	across	
a number of projects), or the provision of personnel directly by the HSE to provide support.
• Taking the lead on coordinating training on the appropriate use of validated tools in a conversational
way as part of the initial assessments with participants. The development of a shared learning 
network of Link Workers, which is already in place who meet regularly to share practice and resources
provides a useful forum to communicate with and assess training needs of Link Workers.
• Supporting	projects	to	communicate	findings	through	the	development	of	an	online	library/
repository of information that can be used to highlight examples and templates of current quality
evaluations as exemplars of good practice and guides for new projects.
• Investing in or supporting the implementation of a shared digital system for data collection that will
enhance the consistency and congruence of how information is collated and reported.
Building the Capacity for the Evaluation of Social Prescribing: An Evaluability Assessment
56 57
9.4.4. Recommendation 4
The HSE is currently working on a framework for the development and sustainable integration of Social 
Prescribing in the HSE in consultation with key partners including the All-Island Social Prescribing 
Network, HSE cross sectoral partners, DOH and the C&V sector. It is recommended that this framework 
includes specific measurable objectives for mainstreaming with appropriate timescales and actions. 
Furthermore, the All-Island Social Prescribing Network should consider how the Minimum Data Outcomes 
Framework and proposed evaluation approaches can advance these goals and consider how it can support 
the implementation of enhanced evaluation approaches across its network of members.
9.4.5. Recommendation 5
Once tested further as per recommendation 1 and 2, it is recommended that the Minimum 
Data Outcomes Framework be enhanced by converting the content into a practical workbook and 
toolkit which can be distributed and disseminated to projects. This could be combined with the 
implementation of recommendation 3 as part of the body of support for projects.
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APPENDIX 1 – OVERVIEW OF 12 SOCIAL PRESCRIBING PROJECTS
Primary Reason for 
Referral





social isolation, mental 
wellbeing, anxiety, stress
social isolation, mental 
wellbeing
mild mental health issues, 
social isolation





high GP attendance, 
mental health
social isolation, mild 
mental health
social isolation, mental 
health, general health
social isolation, mental 
health
general health & 
wellbeing, mental health





























































































































APPENDIX 2 – LIST OF CONSULTEES
1. Health Service Executive Health & Wellbeing
2.	Health	Service	Executive	National	Office	Suicide	Prevention
3. Department of Health, Sláintecare
4. Trinity College Dublin (Discipline of Occupational Therapy)
5. Waterford Social Prescribing Service (Sacred Heart Family Resource Centre)
6. Listowel Family Resource Centre
7. Wicklow County Partnership
8. Bray Area Partnership
9. South Dublin County Partnership
10. Rosses Social Prescribing Project
11. The Flourish Project (Family Centre Castlebar)
12. Southside Partnership
13. Fatima Groups United
14. Tallaght Cross GP Practice
15. Local Asset Mapping Project St James Hospital
16. Bogside Brandywell Health Forum
17. The Healthy Living Centre Alliance
18.	Offaly	Local	Development	Company
19. Silver Arch Family Resource Centre
20. Letterkenny Youth and Family Service
21. Gaoth Dobhair Social Prescribing Project
22. Derryveagh Social Prescribing Project
23.	Lifford	Clonleigh	Resource	Centre
24. Inishowen Development Partnership
25. Bromley By Bow Centre
26. Marie Polley Consultancy
27. Dublin City Sport & Wellbeing partnership
28. Social Prescribing Network Ireland
29. Social Prescribing Network England
30. National Clinical Lead for Social Prescription (NHS)
31. Managing Director TVC’s Green Gym and National Lottery Community Fund Quality Assurance Lead
for Social Prescribing
32. Helium Arts
33. Clones Family Resource Centre
34. Dun Laoghaire Rathdown Sports Partnership
35. Attendees at All Ireland Social Prescribing Conference (Waterford, December 2019)
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APPENDIX 3 - FURTHER DETAIL ON OUTCOMES
Personal Wellbeing
‘Measuring Wellbeing’ refers to how people are in themselves – their emotions, judgements and 
experiences43. The New Economics Foundation (NEF 2012) reference external factors like housing, income, 
education and social networks as ‘drivers of wellbeing’ and ‘internal’ things such as health, optimism and 
self-esteem,	which	 influence	how	people	feel	and	function.	This	 is	captured	 in	the	NEF	2008	model	of	
wellbeing	(developed	as	part	of	the	Government	Office	for	Science’s	Foresight	Project	on	Mental	Capital	
and Wellbeing).
“The model describes how an individual’s external conditions (bottom left) – such as their income, 
employment status and social networks – act together with their personal resources (bottom right) – such 
as their health, resilience and optimism – to allow them to function well (middle) in their interactions with 
the world and therefore experience positive emotions (top). When people function well and experience 
positive	emotions	day-to-day	and	overall,	we	can	think	of	them	as	‘flourishing’44.
43 Measuring Wellbeing A guide for practitioners. New Economics Foundation 2012
44 Measuring Wellbeing A guide for practitioners. New Economics Foundation 2012
Social Connectedness/Social Wellbeing
Workshop participants associated strong social connectedness with positive wellbeing. Social 
connectedness in these cases referred to the availability of and willingness to access support within a 
participant’s local community, focusing on the extent to which people felt close enough to family, friends, 
organisations or professionals to enable them to participate socially in society or positive activity.
There is a wide body of literature and research identifying that individuals with a higher sense of social 
connectedness are likely to be more socially active, to perceive others in a more positive manner, and to 
engage in relationships more easily. In contrast, low social connectedness is associated with experiencing 
discomfort in social situations, feeling isolated and relationship dissatisfaction45. Social connectedness, as 
assessed	by	the	Social	Connectedness	Scale	and	the	Revised	Social	Connectedness	Scale	is	significantly	
associated with anxiety, self–esteem, perceived stress, depression, social discomfort, and hostility, such 
that high social connectedness appears to serve as a protective factor with regard to a range of symptoms 
of psychological distress46.
In	addition,	other	research	identifies	that	people	who	feel	socially	integrated,	close	to,	and	deriving	comfort	
from others in their community, are more likely to feel like they live in a healthy neighbourhood, perceive 
neighbours as trustworthy and safe and volunteer to maintain their neighbourhoods47. This aligns with the 
Social Prescribing models presented throughout Ireland.
45 Lee, R.	M.,	&	Robbins,	S.	B.	(1998).	The	relationship	between	social	connectedness	and	anxiety,	self-esteem,	and	social	identity	[Editorial].	Journal	of	Counseling	Psychology,	
45(3),	338–345 
46 Lee, R. M., Draper, M., & Lee, S. (2001). Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: Testing a mediator model. Journal of 
Counseling Psychology, 48(3), 310–318
47 Keyes, R. L., (1998). Social Wellbeing, Social Psychology Quarterly, 61(2) 121-140
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APPENDIX 4 – PARTICIPANT PROFILE DATA SAMPLE FORM












Referral Info  Referral Date
Being referred by whom
Reason for Referral
Relevant Medical
Information   Medical Number








GP/ED/PCT  No of GP appointments in the past 6 months
No of ED appointments in the past 6 months
Urgency/Risks  Urgency
Risks associated when working with an individual
Patient Consent  Patient Agrees
APPENDIX 5 – SURVEYS TO GPS
The following is a sample list of questions that can be converted to an online survey and distributed to 
relevant GP practices or PCTs within the Social Prescribing Project locality. The sample survey questions 
are based on the Bromley By Bow Social Prescribing Service.
1. In which GP practice are you based? (provide drop down list of relevant local GP practices)
2. What best describes your profession? (provide drop down list of GPs, Mental Health Liaison Nurse,
Social Worker, Occupational Therapist, Practice Nurse, Practice Manager)
3. Are you aware of the {insert name} Social Prescribing service? (yes/no)
4. Have you referred to the Social Prescribing service since [insert	timeframe	of	last	project	year]? 
(provide drop down list of yes/no)
5. If you haven’t made a referral, please indicate why not?
6. If you have made a referral, was the process easy and straightforward? (provide drop down list of 
yes, no, somewhat)
7. Do you agree that overall, patients respond well to the suggestion of Social Prescribing? (provide
Likert scale: strongly agree – strongly disagree)
8. Do you think that Social Prescribing brings benefits to the wellbeing of your patients? (provide 
drop down list of yes/no/somewhat)
9. Please Explain
10. Do you think that Social Prescribing brings benefits to you as a clinician? (provide drop down list
of yes/no/somewhat
11. Please Explain
12. How do you prefer to hear about services and developments that support referred patients?
(provide	a	drop	down	of	direct	email,	letter,	leaflets,	presentations	-	Tick	those	that	apply)
13. Please state any improvements you would like to see made to the service
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